Filing Details
- Accession Number:
- 0001104659-24-040517
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-28 16:08:37
- Reporting Period:
- 2024-03-26
- Accepted Time:
- 2024-03-28 16:08:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1400118 | Sagimet Biosciences Inc. | SGMT | Pharmaceutical Preparations (2834) | 205991472 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1623567 | David Happel | Sagimet Biosciences Inc. 155 Bovet Rd., Suite 303 San Mateo CA 94402 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Series A Common Stock | Acquisiton | 2024-03-26 | 12,100 | $5.27 | 639,200 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Reflects the weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.24 per share to $5.2999 per share. The Reporting Person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each price.
Billionaire Hedge Funds
